Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-072154·NeuroPace Inc
Schedule 13G ownership disclosure
NeuroPace Inc
Common Stock, par value $0.001 per share · CUSIP: 641288105
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Private Equity Fund I, L.P.
Shares: 310,321.00 · Class: 0.9%
- Soleus Private Equity GP I, LLC
Shares: 310,321.00 · Class: 0.9%
- Soleus PE GP I, LLC
Shares: 310,321.00 · Class: 0.9%
- Soleus Capital Master Fund, L.P.
Shares: 1,993,507.00 · Class: 6.1%
- Soleus Capital, LLC
Shares: 1,993,507.00 · Class: 6.1%
- Soleus Capital Group, LLC
Shares: 1,993,507.00 · Class: 6.1%
- Soleus Capital Management, L.P.
Shares: 2,303,828.00 · Class: 7.0%
- Soleus GP, LLC
Shares: 2,303,828.00 · Class: 7.0%
- Guy Levy
Shares: 2,303,828.00 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-072154
- Form type
- SCHEDULE 13G/A
- Filer
- NeuroPace Inc
- CIK
- CIK 1528287
- Filed
- Aug 05, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership